• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口干症预测列线图用于调强放疗后鼻咽癌患者。

Prognostic nomogram of xerostomia for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy.

机构信息

Department of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi 530021, P.R. China.

出版信息

Aging (Albany NY). 2020 Jan 31;12(2):1857-1866. doi: 10.18632/aging.102717.

DOI:10.18632/aging.102717
PMID:32005029
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7053606/
Abstract

Xerostomia is a common radiation-induced late complication after radiotherapy. Identifying predictive factors for xerostomia will lead to better treatments and improve the quality of life. This study was conducted to establish an effective predictive nomogram for xerostomia by assessing stage I-IVb (AJCC 7th edition) NPC patients between September 2015 and March 2016. Xerostomia was evaluated via the RTOG/EORTC system. The primary endpoint was grade 2-3 xerostomia 1 year after treatment. The predictive factors for xerostomia were analysed using logistic regression analysis. A nomogram was constructed based on combining the predictors and clinical variables. In total, 102 patients with grade 0-1 xerostomia and 93 patients with grade 2-3 xerostomia were included. The independent predictive factors for xerostomia were V25, V30, V35, and V45 of the ipsilateral parotid gland and mean dose of the contralateral parotid gland. The calibration plot for the probability of xerostomia showed good agreement between prediction by the nomogram and actual observation. The concordance index of the nomogram for predicting xerostomia was 0.796 (95% CI: 0.735-0.857, P <0.001), which was higher than any single dosimetric parameter. Our results indicated that the nomogram provided a more accurate prediction of grade 2-3 xerostomia 1 year after treatment.

摘要

口干症是放疗后常见的晚期放射性损伤。确定口干症的预测因素将有助于制定更好的治疗方案,提高生活质量。本研究旨在通过评估 2015 年 9 月至 2016 年 3 月间 I-IVb 期(AJCC 第 7 版)NPC 患者,建立一种有效的口干症预测列线图。采用 RTOG/EORTC 系统评估口干症。主要终点为治疗后 1 年发生 2-3 级口干症。采用 logistic 回归分析口干症的预测因素。基于预测因子和临床变量构建列线图。共纳入 102 例口干症 0-1 级和 93 例口干症 2-3 级患者。同侧腮腺 V25、V30、V35 和 V45 以及对侧腮腺平均剂量是口干症的独立预测因子。口干症概率的校准图显示,列线图预测与实际观察之间具有良好的一致性。列线图预测口干症的一致性指数为 0.796(95%CI:0.735-0.857,P<0.001),高于任何单一剂量学参数。研究结果表明,该列线图能更准确地预测治疗后 1 年 2-3 级口干症的发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6739/7053606/bb2e29192e7f/aging-12-102717-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6739/7053606/115e5ac1b9ac/aging-12-102717-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6739/7053606/770ddff566b7/aging-12-102717-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6739/7053606/fe4104e9182d/aging-12-102717-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6739/7053606/bb2e29192e7f/aging-12-102717-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6739/7053606/115e5ac1b9ac/aging-12-102717-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6739/7053606/770ddff566b7/aging-12-102717-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6739/7053606/fe4104e9182d/aging-12-102717-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6739/7053606/bb2e29192e7f/aging-12-102717-g004.jpg

相似文献

1
Prognostic nomogram of xerostomia for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy.口干症预测列线图用于调强放疗后鼻咽癌患者。
Aging (Albany NY). 2020 Jan 31;12(2):1857-1866. doi: 10.18632/aging.102717.
2
A nomogram for predicting late radiation-induced xerostomia among locoregionally advanced nasopharyngeal carcinoma in intensity modulated radiation therapy era.调强放疗时代局部晚期鼻咽癌患者放射性口干预测列线图的建立。
Aging (Albany NY). 2021 Jul 19;13(14):18645-18657. doi: 10.18632/aging.203308.
3
Predictors for improvement of xerostomia in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy.接受调强放疗的鼻咽癌患者口干改善的预测因素
Medicine (Baltimore). 2019 Sep;98(36):e17030. doi: 10.1097/MD.0000000000017030.
4
Prognosis viewing for nasopharyngeal carcinoma treated with intensity-modulated radiation therapy: application of nomogram and decision curve analysis.调强放疗治疗鼻咽癌的预后观察:列线图和决策曲线分析的应用。
Jpn J Clin Oncol. 2020 Feb 17;50(2):159-168. doi: 10.1093/jjco/hyz165.
5
Development and validation of a nomogram for prediction of recovery from moderate-severe xerostomia post-radiotherapy in nasopharyngeal carcinoma patients.制定和验证预测鼻咽癌患者放疗后中重度口干恢复的列线图。
Radiother Oncol. 2023 Jul;184:109683. doi: 10.1016/j.radonc.2023.109683. Epub 2023 Apr 28.
6
Prognostic Nomogram For Locoregionally Advanced Nasopharyngeal Carcinoma.局部晚期鼻咽癌预后列线图
Sci Rep. 2020 Jan 21;10(1):861. doi: 10.1038/s41598-020-57968-x.
7
Prognostic Nomogram for Patients with Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy.调强放疗后鼻咽癌患者的预后列线图
PLoS One. 2015 Aug 6;10(8):e0134491. doi: 10.1371/journal.pone.0134491. eCollection 2015.
8
The value of detailed MR imaging report of primary tumor and lymph nodes on prognostic nomograms for nasopharyngeal carcinoma after intensity-modulated radiotherapy.调强放疗后鼻咽癌预后列线图中原发肿瘤及淋巴结详细磁共振成像报告的价值。
Radiother Oncol. 2019 Feb;131:35-44. doi: 10.1016/j.radonc.2018.11.001. Epub 2018 Dec 20.
9
Prognostic nomogram to predict the distant metastasis after intensity-modulated radiation therapy for patients with nasopharyngeal carcinoma.预测鼻咽癌调强放疗后远处转移的预后列线图。
Medicine (Baltimore). 2021 Nov 24;100(47):e27947. doi: 10.1097/MD.0000000000027947.
10
Proposal of a Pretreatment Nomogram for Predicting Local Recurrence after Intensity-Modulated Radiation Therapy in T4 Nasopharyngeal Carcinoma: A Retrospective Review of 415 Chinese Patients.T4 期鼻咽癌调强放疗后局部复发的预处理列线图预测:来自 415 例中国患者的回顾性研究。
Cancer Res Treat. 2018 Oct;50(4):1084-1095. doi: 10.4143/crt.2017.359. Epub 2017 Nov 15.

引用本文的文献

1
Contouring the accessory parotid gland and major parotid glands as a single organ at risk during nasopharyngeal carcinoma radiotherapy.在鼻咽癌放疗期间,将副腮腺和腮腺作为一个单一的危险器官进行轮廓勾画。
Front Oncol. 2022 Nov 11;12:958961. doi: 10.3389/fonc.2022.958961. eCollection 2022.
2
Application of Diffusion Kurtosis Imaging in Evaluating Acute Xerostomia in Nasopharyngeal Carcinoma Treated With Induction Chemotherapy Plus Concurrent Chemoradiotherapy.扩散峰度成像在评估诱导化疗联合同期放化疗的鼻咽癌急性口干症中的应用
Front Oncol. 2022 May 19;12:870315. doi: 10.3389/fonc.2022.870315. eCollection 2022.
3

本文引用的文献

1
Clinical and dosimetric predictors of physician and patient reported xerostomia following intensity modulated radiotherapy for nasopharyngeal cancer - A prospective cohort analysis.鼻咽癌调强放疗后口干症的临床和剂量学预测因素——一项前瞻性队列分析。
Radiother Oncol. 2019 Sep;138:149-157. doi: 10.1016/j.radonc.2019.05.023. Epub 2019 Jun 29.
2
Long-Term Late Toxicity, Quality of Life, and Emotional Distress in Patients With Nasopharyngeal Carcinoma Treated With Intensity Modulated Radiation Therapy.调强放疗治疗鼻咽癌患者的长期迟发性毒性、生活质量和情绪困扰。
Int J Radiat Oncol Biol Phys. 2018 Oct 1;102(2):340-352. doi: 10.1016/j.ijrobp.2018.05.060. Epub 2018 Jun 4.
3
A nomogram for predicting late radiation-induced xerostomia among locoregionally advanced nasopharyngeal carcinoma in intensity modulated radiation therapy era.
调强放疗时代局部晚期鼻咽癌患者放射性口干预测列线图的建立。
Aging (Albany NY). 2021 Jul 19;13(14):18645-18657. doi: 10.18632/aging.203308.
Comparison of the efficacy between intensity-modulated radiotherapy and two-dimensional conventional radiotherapy in stage II nasopharyngeal carcinoma.
调强放疗与二维常规放疗治疗Ⅱ期鼻咽癌的疗效比较。
Oncotarget. 2017 Apr 27;8(44):78096-78104. doi: 10.18632/oncotarget.17481. eCollection 2017 Sep 29.
4
Concurrent chemoradiotherapy degrades the quality of life of patients with stage II nasopharyngeal carcinoma as compared to radiotherapy.与放射治疗相比,同步放化疗会降低II期鼻咽癌患者的生活质量。
Oncotarget. 2017 Feb 21;8(8):14029-14038. doi: 10.18632/oncotarget.14932.
5
IMRT for head and neck cancer: reducing xerostomia and dysphagia.头颈部癌的调强放射治疗:减少口干和吞咽困难。
J Radiat Res. 2016 Aug;57 Suppl 1(Suppl 1):i69-i75. doi: 10.1093/jrr/rrw047.
6
A prospective study on radiation doses to organs at risk (OARs) during intensity-modulated radiotherapy for nasopharyngeal carcinoma patients.一项关于鼻咽癌患者调强放射治疗期间危及器官(OARs)辐射剂量的前瞻性研究。
Oncotarget. 2016 Apr 19;7(16):21742-52. doi: 10.18632/oncotarget.7826.
7
Cancer statistics in China, 2015.《中国癌症统计数据 2015》
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32. doi: 10.3322/caac.21338. Epub 2016 Jan 25.
8
Long-term patterns of relapse and survival following definitive intensity-modulated radiotherapy for non-endemic nasopharyngeal carcinoma.非地方性鼻咽癌根治性调强放疗后的长期复发和生存模式
Oral Oncol. 2016 Feb;53:67-73. doi: 10.1016/j.oraloncology.2015.11.015. Epub 2015 Dec 7.
9
Survivorship and Quality of Life in Head and Neck Cancer.头颈部癌症的生存与生活质量
J Clin Oncol. 2015 Oct 10;33(29):3322-7. doi: 10.1200/JCO.2015.61.4115. Epub 2015 Sep 8.
10
Analysis of late toxicity in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy.调强放射治疗鼻咽癌患者的晚期毒性分析。
Radiat Oncol. 2015 Jan 13;10:17. doi: 10.1186/s13014-014-0326-z.